Tiziana Tiziana生命科学报告说,在研究中,Ozempic和Nasal抗CD3的结合取得了积极成果。 Tiziana Life Sciences reports positive results for combination of Ozempic and nasal anti-CD3 in study.

Tiziana Tiziana生命科学报告了一项研究的积极成果,该项研究对Ozempic和Nasal抗CD3的结合进行了研究。 Tiziana Life Sciences has reported positive results from a study examining the combination of Ozempic and nasal anti-CD3. 这项研究表明,二恶英药物的潜在好处可能对治疗战略产生影响。 This research suggests potential benefits of the drug duo, which could have implications for treatment strategies. 没有具体说明关于研究方法和结果的进一步细节。 Further details about the study's methodology and outcomes were not specified.